Achiko AG

PINK:ACHKF USA Health Information Services
Market Cap
$377.40K
Market Cap Rank
#38392 Global
#12491 in USA
Share Price
$0.00
Change (1 day)
+0.00%
52-Week Range
$0.00 - $0.00
All Time High
$0.45
About

Achiko AG engages in developing disruptive diagnostic solutions in Indonesia and internationally. The company's lead product is AptameX, a rapid test that uses DNA aptamers instead of antigens to detect the SARS-CoV-2 virus. It also offers Teman Sehat, a mobile check-in and passport application. In addition, the company provides secure payment solutions for game publishers and application develop… Read more

Achiko AG (ACHKF) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of June 2022: 0.000x

Based on the latest financial reports, Achiko AG (ACHKF) has a cash flow conversion efficiency ratio of 0.000x as of June 2022.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-497.80) by net assets ($-6.91 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Achiko AG - Cash Flow Conversion Efficiency Trend (2018–2021)

This chart illustrates how Achiko AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Achiko AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Achiko AG ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Achiko AG (2018–2021)

The table below shows the annual cash flow conversion efficiency of Achiko AG from 2018 to 2021.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2021-12-31 $-4.58 Million $-5.25 Million 1.146x -3.92%
2020-12-31 $-4.05 Million $-4.83 Million 1.192x +130.48%
2019-12-31 $1.91 Million $-7.47 Million -3.912x -619.79%
2018-12-31 $-625.49K $339.95K -0.543x --